San Diego, CA -- (SBWIRE) -- 12/14/2020 -- Sona Nanotech Inc is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Sona Nanotech Inc. (OTC: SNANF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Sona Nanotech Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Canada based Sona Nanotech Inc., nanotechnology life sciences company, manufactures gold nanorod products for diagnostic test. On October 29, 2020, Sona Nanotech Inc. announced that the Food and Drug Administration ("FDA") denied the Company's request for an emergency use authorization for the marketing of its rapid COVID-19 antigen test in the United States.

Those who purchased shares of Sona Nanotech Inc. (OTC: SNANF) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.